Agenus Inc
Biotechnology
Healthcare
AGEN
21.55 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.67
52 week high
17.73
high
1.80
52 week low
1.51
low
1.58
growth
-88.97 %
previous Close
1.70
P/E ratio
-1
market cap
64.22 M
div yield
0
usd
Sep 2024
qoq
revenue
25.11 M
6.82 %
net incoming
-66.39 M
-25.07 %
eps
-3.08 %
-22.22 %
eps surprise
-32.19 %
net profit margin
-264.36 %
-38.00 %
operating incoming
-31.50 M
-4.34 %
net change in cash
-45.31 M
-210.86 %
cash on hand
44.78 M
-52.22 %
cost of revenue
41.20 M
35.00 %
top top